Company Overview and News

 
Deals of the day-Mergers and acquisitions

2018-05-22 reuters
May 22 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Tuesday:

 
Five things to watch for this company earnings season

2018-02-04 theage.com.au
Earnings season kicks off this month, with shareholders keen to know how the nation's top companies are handling overseas competition and performing in lucrative new markets.

 
Five things to watch for this company earnings season

2018-02-04 smh.com.au
Earnings season kicks off this month, with shareholders keen to know how the nation's top companies are handling overseas competition and performing in lucrative new markets.

 
What to Watch For as Australia's Earnings Season Kicks Off - Bloomberg

2018-02-04 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
ASX rallies hard for first weekly gain in three weeks

2017-10-06 smh.com.au
The Australian market for once joined in with other global equity markets and rallied hard on Friday, with the gains helping the index mark its first positive week in three.

 
ASX rallies hard for first weekly gain in three weeks

2017-10-06 theage.com.au
The Australian market for once joined in with other global equity markets and rallied hard on Friday, with the gains helping the index mark its first positive week in three.

 
Analysts and fund managers eye ASX reset in traditionally stronger July

2017-07-03 smh.com.au
After May's heavy selling and June's doldrums, analysts and fund managers believe ASX investors could see a reset in July.

 
Analysts and fund managers eye ASX reset in traditionally stronger July

2017-07-03 theage.com.au
After May's heavy selling and June's doldrums, analysts and fund managers believe ASX investors could see a reset in July.

 
Last week for tax-loss selling before the July bounce

2017-06-18 theage.com.au
Tax loss selling has hammered some shares this season, but the strategy is gearing up to have one last wash through the ASX this week before the July pickup.

 
Last week for tax-loss selling before the July bounce

2017-06-18 smh.com.au
Tax loss selling has hammered some shares this season, but the strategy is gearing up to have one last wash through the ASX this week before the July pickup.

 
Miners, big banks lead the charge on ASX

2017-05-22 smh.com.au
Resource stocks surged on Monday, providing the index with a solid start to the week after last week's almost 2 per cent drop.

 
Miners, big banks lead the charge on ASX

2017-05-22 theage.com.au
Resource stocks surged on Monday, providing the index with a solid start to the week after last week's almost 2 per cent drop.

 
Deals of the day-Mergers and acquisitions

2017-05-19 reuters
May 19 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:

 
oOh!Media and APN drop $1.6 billion merger after competition concerns

2017-05-19 theage.com.au
Media companies oOh!media and APN Outdoor Group have dropped plans to merge into a $1.6 billion billboard advertising powerhouse after conceding the deal would not get past the competition regulator. 

 
oOh!Media and APN drop $1.6 billion merger after competition concerns

2017-05-19 smh.com.au
Media companies oOh!media and APN Outdoor Group have dropped plans to merge into a $1.6 billion billboard advertising powerhouse after conceding the deal would not get past the competition regulator. 

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...